MY ACCOUNT | NEWSLETTER |

Helping cartilage heal itself

Cornell researchers offer new explanation of how stem cells can prevent cartilage loss, chronic pain after joint injury


Story by Sheri Hall, Cornell University College of Veterinary Medicine

An interdisciplinary team of Cornell researchers led by Dr. Michelle Delco, D.V.M., has made a series of discoveries that offer a new explanation of how stem cells can prevent cartilage loss and chronic pain after joint injury, a development that paves the way for new arthritis treatments in animals and humans.

“Cartilage is an amazing tissue,” said Delco, the Harry M. Zweig Assistant Professor in Equine Health and a large animal orthopedic surgeon at the Cornell Hospital for Animals. “It provides shock absorption and joint lubrication every time we take a step. It has to endure a lifetime of wear and tear, but has little or no ability to heal. Even after decades of research, we have no reliable treatments to prevent arthritis after a joint injury.”

For the past 30 years, researchers have been exploring mesenchymal stromal cells (MSCs), a type of adult stem cell, to promote healing of many tissue types. But results have varied widely, and it remains unclear how MSCs work. Initially, researchers thought that since these cells have the ability to transform into many cell types, MSCs would directly replace damaged tissues. However, recent evidence suggests MSCs instead help injured tissue heal itself.

In a study published in the journal Scientific Reports, Delco and her team discovered stem cell’s healing properties may come down to mitochondria, tiny structures within the cell often referred to as the “powerhouse” of the cell. In addition to producing energy, mitochondria help dictate when old or injured cells are destroyed and provide building blocks for tissue repair.

Delco’s work showed that stem cells can rescue injured cartilage cells by donating healthy mitochondria, a process called mitochondrial transfer. Previously, Delco’s group discovered that when cartilage is injured, mitochondrial function declines, which leads to cartilage loss and ultimately causes osteoarthritis.

“These results were exciting because they provided a new perspective,” Delco explained. “In the past, we had not really recognized the importance of mitochondria in the development of arthritis. We have learned that if we can find new ways to supplement mitochondrial function, we may find ways to heal cartilage.”

In a series of experiments, Delco and her team marked cartilage cells with a green colored protein, then placed the cells under various stressful conditions. They marked the mitochondria inside stem cells with a red colored protein, and used them to treat the injured cells. When examined under a microscope, they could repeatedly see the stem cell’s mitochondria transfer to the cartilage cells.

The team went on to perform this test in pieces of cartilage tissue. This step relied on a long-standing collaboration between Delco and Dr. Lawrence Bonassar, a professor in Cornell’s Meinig School of Biomedical Engineering whose laboratory focuses on cartilage biomechanics.

Working together, Delco and Bonassar developed a system that can mechanically injure cartilage tissue in a way that mirrors naturally-occurring injuries. They use an impactor – essentially a small, spring-loaded hammer – to injure cartilage tissue in the laboratory or during minimally-invasive joint surgery. “The impactor creates injuries that look very similar to the disease progression that Michelle sees in her patients,” Bonassar said.

In this most recent series of experiments, the research team could actually see the mitochondria at work, Bonassar explained. “If you put stem cells on healthy cartilage, the cells don’t stick,” he said. “But when you put the stem cells on damaged cartilage, they stick to the cracks. In some cases, the stem cells burrow deep into the tissue. They appear to connect directly with cells adjacent to them.”

The next step is to better understand how and why this occurs. “We believe the cartilage cells are calling for help somehow,” Delco said. “We want to find out what signals they are putting out to cause the stem cells to snuggle up to them and share their mitochondria. By understanding how and when transfer happens, we can engineer new treatments to amplify it.”

On this front, Delco's group published a second paper in Frontiers in Bioengineering and Biotechnology. This time, they conducted their experiments on human cartilage cells. They found stem cells package and export their mitochondria in extracellular vesicles, a sort of cellular envelope. They call these mitochondria-containing packages “mitovesicles.”

“We found that stressed cartilage cells can take up these ‘mitovesicles,’ incorporate them into their own mitochondrial networks, and that this improves their function and energy production.” Delco said. “Of course, more work needs to be done on this front, but it’s exciting because it suggests we may be able to use these mitovesicles made by MSCs as a ‘cell-free’ regenerative therapy, rather than using the stem cells themselves.”

Developing a therapy that doesn’t require live cells would be a big step forward because harvesting, growing, and injecting stem cells is more complicated and expensive. “A ‘cell-free’ treatment could be stored and used as needed,” Delco said. “That would remove some of the barriers to regenerative therapy.

“People have been studying how injury leads to cartilage loss and osteoarthritis for a long time – many decades. But we still haven’t found a therapy that can slow down cartilage degeneration, let alone help cartilage regenerate once it’s lost,” she said. “Now we are zeroing in on a strategy to help cartilage heal itself.”

Fahey M, Bennett M, Thomas M, Montney K, Vivancos-Koopman I, Pugliese B, Browning L, Bonassar LJ, Delco M. "Mesenchymal stromal cells donate mitochondria to articular chondrocytes exposed to mitochondrial, environmental, and mechanical stress." Sci Rep. 2022 Dec 13;12(1):21525. doi: 10.1038/s41598-022-25844-5. PMID: 36513773; PMCID: PMC9747781.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Evaluation of 3D additively manufactured canine brain models for teaching veterinary neuroanatomy

Like0
Dislike0

Reasons for whole carcass condemnations of cattle in the United States and implications for producer education and veterinary intervention

Like0
Dislike0

A New Penn Vet Clinic Brings Support and Hope for Dogs with Retinal Disease

Like0
Dislike0

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic

Like0
Dislike0

Cooperation in regional innovation networks among small and medium enterprises: Case study of a veterinary pharmaceutical company in Jalisco, Mexico

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top